4
Changes in Ownership
Summit Therapeutics Inc. Filed Acc 0001599298-24-000135
Chief Accounting Officer acquired 22,026 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Anand Bhaskar · Chief Accounting Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-09-11 | Grant or award : show line 1 in the form | +22,026 | $22.70 | $499,990 | 131,426 | D |
Loading xslF345X05/wk-form4_1726262759.xml…